BNGO · Bionano Genomics, Inc. · Analyst Estimates
$1.00
-0.04 (-3.85%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we determined that there is substantial doubt about our ability to continue as a going concern within 12 months after the date that the financial statements included in this Quarterly Report are issued.”View the 10-Q filed Nov 10, 2026
Market Cap
$13.99M
Shares
13.99M
Volume · Nov 13
557.57K
Avg daily vol (3M)
965.62K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Bionano Genomics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-13 22:27 UTC · Publication dates shown per estimate · 7 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.14
|
-2.14
|
-2.14
|
1
|
-2.13
|
-2.13
|
-2.13
|
-2.71
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
32.47M
|
32.47M
|
32.47M
|
1
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.97
|
-0.97
|
-0.97
|
1
|
-0.97
|
-0.97
|
-0.97
|
-1.11
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
43.30M
|
43.30M
|
43.30M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.39
|
-0.39
|
-0.39
|
1
|
-0.40
|
-0.40
|
-0.40
|
-0.51
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
9.17M
|
9.17M
|
9.17M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
USD
Publication date not stated |
8.40M
|
8.40M
|
8.40M
|
1
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1411690
CUSIP
09075F404
13F (30d)
44 filings
26 filers
Visit website
Investor relations